Nutex Health (NUTX) Receivables (2010 - 2026)

Nutex Health has disclosed Receivables across 17 years of filings, most recently posting $6.3 million for Q1 2026.

• Receivables for Q1 2026 came in at $6.3 million, up 46.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.3 million (up 46.51% YoY), and the FY2025 annual result was $6.0 million, up 66.57% from the prior year.
• Receivables came in at $6.3 million for Q1 2026 at Nutex Health, up from $6.0 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $95.9 million in Q2 2022 to a low of $685428.0 in Q1 2022.
• The 5-year median for Receivables is $4.6 million (2024), against an average of $18.6 million.
• Across the five-year window, Receivables soared 28525.17% in 2022 and sank 98.64% in 2023, its largest moves.
• Nutex Health's Receivables stood at $58.3 million in 2022, then climbed by 0.45% to $58.6 million in 2023, then sank by 93.85% to $3.6 million in 2024, then soared by 66.57% to $6.0 million in 2025, then increased by 5.0% to $6.3 million in 2026.
• The last three Receivables figures came in at $6.3 million (Q1 2026), $6.0 million (Q4 2025), and $7.3 million (Q3 2025), per Business Quant data.